Search research articles
Contact Us
Filters
Showing results (931-940 of 1,171) with videos related to
Page
of 118
Sort By:
Neurourology and Urodynamics
|
August 21, 2009
Predictors of variability in urinary incontinence and overactive bladder symptoms
W F Stewart, V A Minassian, A G Hirsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2010
Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study
Maryam Fouladi, Clinton F Stewart, Susan M Blaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
A four-hour topotecan infusion achieves cytotoxic exposure throughout the neuraxis in the nonhuman primate model: implications for treatment of children with metastatic medulloblastoma
W C Zamboni, A J Gajjar, T D Mandrell, et al.
Clinical Genitourinary Cancer
|
December 22, 2024
Patterns of Failure After Definitive Trimodality Therapy for Muscle-Invasive Bladder Cancer
Nikhil V Kotha, Abhishek Kumar, Paul Riviere, et al.
Cancer Research
|
July 20, 2007
Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution
Kazumasa Takenaka, Jessica A Morgan, George L Scheffer, et al.
Cancer Chemotherapy and Pharmacology
|
July 8, 2005
Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumors
Carlos Rodriguez-Galindo, Kristine R Crews, Clinton F Stewart, et al.
Bone Marrow Transplantation
|
September 14, 1999
Clearance kinetics of CD34+ cells from peripheral blood: an independent predictor of hematologic recovery after high-dose chemotherapy and hematopoietic stem cell transplantation
L D'Hondt, J Wuu, M André, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
Pharmacokinetics of irinotecan and its metabolites SN-38 and APC in children with recurrent solid tumors after protracted low-dose irinotecan
M K Ma, W C Zamboni, K M Radomski, et al.
Neuro-Oncology
|
February 5, 2011
A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium
Ian F Pollack, Clinton F Stewart, Mehmet Kocak, et al.
Journal of Leukocyte Biology
|
April 1, 1994
Selective regulation of human neutrophil functions by the cell activation inhibitor CI-959
C D Wright, S F Stewart, P J Kuipers, et al.
Page
of 118
Search research articles
Search
Showing results (931-940 of 1,171) with videos related to
Sort By:
Page
of 118
Neurourology and Urodynamics
|
August 21, 2009
Predictors of variability in urinary incontinence and overactive bladder symptoms
W F Stewart, V A Minassian, A G Hirsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2010
Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study
Maryam Fouladi, Clinton F Stewart, Susan M Blaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
A four-hour topotecan infusion achieves cytotoxic exposure throughout the neuraxis in the nonhuman primate model: implications for treatment of children with metastatic medulloblastoma
W C Zamboni, A J Gajjar, T D Mandrell, et al.
Clinical Genitourinary Cancer
|
December 22, 2024
Patterns of Failure After Definitive Trimodality Therapy for Muscle-Invasive Bladder Cancer
Nikhil V Kotha, Abhishek Kumar, Paul Riviere, et al.
Cancer Research
|
July 20, 2007
Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution
Kazumasa Takenaka, Jessica A Morgan, George L Scheffer, et al.
Cancer Chemotherapy and Pharmacology
|
July 8, 2005
Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumors
Carlos Rodriguez-Galindo, Kristine R Crews, Clinton F Stewart, et al.
Bone Marrow Transplantation
|
September 14, 1999
Clearance kinetics of CD34+ cells from peripheral blood: an independent predictor of hematologic recovery after high-dose chemotherapy and hematopoietic stem cell transplantation
L D'Hondt, J Wuu, M André, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
Pharmacokinetics of irinotecan and its metabolites SN-38 and APC in children with recurrent solid tumors after protracted low-dose irinotecan
M K Ma, W C Zamboni, K M Radomski, et al.
Neuro-Oncology
|
February 5, 2011
A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium
Ian F Pollack, Clinton F Stewart, Mehmet Kocak, et al.
Journal of Leukocyte Biology
|
April 1, 1994
Selective regulation of human neutrophil functions by the cell activation inhibitor CI-959
C D Wright, S F Stewart, P J Kuipers, et al.
Page
of 118